Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Biphenotypic, Acute 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Down Syndrome 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

Vincristine 3pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2Methotrexate 2Dexamethasone 2Calcium Dobesilate 2venetoclax 1azathiopurine 1auricularum 1Vorinostat 1Thioguanine 1Spinal Puncture 1Specimen Handling 1Mitoxantrone 1Mercaptopurine 1Magnetic Resonance Spectroscopy 1Leucovorin 1Inotuzumab Ozogamicin 1Doxorubicin 1Decitabine 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × azathiopurine × Clear all
NCT01190930 2026-05-28

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Children's Oncology Group

Phase 3 Completed
9,350 enrolled 51 charts
LymphoidOther hematologic neoplasm

Down Syndrome, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡